▶ 調査レポート

フェキソフェナジンの世界市場レポート2020

• 英文タイトル:Global Fexofenadine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。フェキソフェナジンの世界市場レポート2020 / Global Fexofenadine Sales Market Report 2020 / 20QY06-03161資料のイメージです。• レポートコード:20QY06-03161
• 出版社/出版日:QYResearch / 2020年6月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、145ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥600,000 (USD4,000)▷ お問い合わせ
  Multi User¥900,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,200,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、フェキソフェナジンのグローバル市場について種類別(純度:98%、純度:98%以上)、用途別(花粉症治療、じんましん治療)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・フェキソフェナジン市場の概要
・世界の主要地域別フェキソフェナジン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のフェキソフェナジン市場規模2015-2026:種類別(純度:98%、純度:98%以上)
・世界のフェキソフェナジン市場規模2015-2026:用途別(花粉症治療、じんましん治療)
・フェキソフェナジンの北米市場規模2015-2020
・フェキソフェナジンのヨーロッパ市場規模2015-2020
・フェキソフェナジンの中国市場規模2015-2020
・フェキソフェナジンの日本市場規模2015-2020
・フェキソフェナジンの東南アジア市場規模2015-2020
・フェキソフェナジンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Viruj Pharma、Cemex Pharma、Smaart Pharmaceutticals、Titan Pharma、AFCL、Synkromax、Farmhispania、Gen Pharma、Admiron Life Sciences Private Limited、JRC、Archerchem、Sibram、Sumitomo Chemical、Panchsheel、CAMEO HEALTH CARE、CEPiA-Sanofi、Va Sudha Pharma Chem Limited、VPL Chemicals、Zhejiang Excel Pharmaceutical)
・フェキソフェナジンの製造コスト分析
・販売チャネル、流通業者、顧客
・フェキソフェナジンの市場動向・機会・課題
・調査の結論

Fexofenadine is an allergic symptom in a drug against an antihistamine, such as for the treatment of hay fever and urticaria. Treatment, fexofenadine is a selective peripheral H1 receptor blocker

Market Analysis and Insights: Global Fexofenadine Market
The global Fexofenadine market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Fexofenadine Scope and Market Size
The global Fexofenadine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Fexofenadine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Fexofenadine market is segmented into
Purity:98%
Purity:Above 98%

Segment by Application, the Fexofenadine market is segmented into
Hay Fever Treatment
Urticaria Treatment
The Fexofenadine market is analysed and market size information is provided by regions (countries). Segment by Application, the Fexofenadine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Fexofenadine Market Share Analysis
Fexofenadine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Fexofenadine business, the date to enter into the Fexofenadine market, Fexofenadine product introduction, recent developments, etc.
The major vendors covered:
Viruj Pharma
Cemex Pharma
Smaart Pharmaceutticals
Titan Pharma
AFCL
Synkromax
Farmhispania
Gen Pharma
Admiron Life Sciences Private Limited
JRC
Archerchem
Sibram
Sumitomo Chemical
Panchsheel
CAMEO HEALTH CARE
CEPiA-Sanofi
Va Sudha Pharma Chem Limited
VPL Chemicals
Zhejiang Excel Pharmaceutical

レポート目次

Table of Contents

1 Fexofenadine Market Overview
1.1 Fexofenadine Product Scope
1.2 Fexofenadine Segment by Type
1.2.1 Global Fexofenadine Sales by Type (2020-2026)
1.2.2 Purity:98%
1.2.3 Purity:Above 98%
1.3 Fexofenadine Segment by Application
1.3.1 Global Fexofenadine Sales Comparison by Application (2020-2026)
1.3.2 Hay Fever Treatment
1.3.3 Urticaria Treatment
1.4 Fexofenadine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Fexofenadine Sales Growth Rate (2015-2026)
1.4.2 Global Fexofenadine Revenue and Growth Rate (2015-2026)
1.4.3 Global Fexofenadine Price Trends (2015-2026)

2 Fexofenadine Estimate and Forecast by Region
2.1 Global Fexofenadine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Fexofenadine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Fexofenadine Sales Market Share by Region (2015-2020)
2.2.2 Global Fexofenadine Revenue Market Share by Region (2015-2020)
2.3 Global Fexofenadine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Fexofenadine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Fexofenadine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Fexofenadine Estimates and Projections (2015-2026)
2.4.2 Europe Fexofenadine Estimates and Projections (2015-2026)
2.4.3 China Fexofenadine Estimates and Projections (2015-2026)
2.4.4 Japan Fexofenadine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Fexofenadine Estimates and Projections (2015-2026)
2.4.6 India Fexofenadine Estimates and Projections (2015-2026)
3 Global Fexofenadine Competition Landscape by Players
3.1 Global Top Fexofenadine Players by Sales (2015-2020)
3.2 Global Top Fexofenadine Players by Revenue (2015-2020)
3.3 Global Fexofenadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fexofenadine as of 2019)
3.4 Global Fexofenadine Average Price by Company (2015-2020)
3.5 Manufacturers Fexofenadine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Fexofenadine Players (Opinion Leaders)
4 Global Fexofenadine Market Size by Type
4.1 Global Fexofenadine Historic Market Review by Type (2015-2020)
4.1.1 Global Fexofenadine Sales Market Share by Type (2015-2020)
4.1.2 Global Fexofenadine Revenue Market Share by Type (2015-2020)
4.1.3 Global Fexofenadine Price by Type (2014-2020)
4.2 Global Fexofenadine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Fexofenadine Sales Forecast by Type (2021-2026)
4.2.2 Global Fexofenadine Revenue Forecast by Type (2021-2026)
4.2.3 Global Fexofenadine Price Forecast by Type (2021-2026)
5 Global Fexofenadine Market Size by Application
5.1 Global Fexofenadine Historic Market Review by Application (2015-2020)
5.1.1 Global Fexofenadine Sales Market Share by Application (2015-2020)
5.1.2 Global Fexofenadine Revenue Market Share by Application (2015-2020)
5.1.3 Global Fexofenadine Price by Application (2015-2020)
5.2 Global Fexofenadine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Fexofenadine Sales Forecast by Application (2021-2026)
5.2.2 Global Fexofenadine Revenue Forecast by Application (2021-2026)
5.2.3 Global Fexofenadine Price Forecast by Application (2021-2026)

3 North America Fexofenadine Market Facts & Figures
3.2 North America Fexofenadine Sales Market Share by Company (2015-2020)
3.3 North America Fexofenadine Sales Market Share by Type (2015-2020)
3.4 North America Fexofenadine Sales Market Share by Application (2015-2020)

4 Europe Fexofenadine Market Facts & Figures
4.2 Europe Fexofenadine Sales Market Share by Company (2015-2020)
4.3 Europe Fexofenadine Sales Market Share by Type (2015-2020)
4.4 Europe Fexofenadine Sales Market Share by Application (2015-2020)

5 China Fexofenadine Market Facts & Figures
5.2 China Fexofenadine Sales Market Share by Company (2015-2020)
5.3 China Fexofenadine Sales Market Share by Type (2015-2020)
5.4 China Fexofenadine Sales Market Share by Application (2015-2020)

6 Japan Fexofenadine Market Facts & Figures
6.2 Japan Fexofenadine Sales Market Share by Company (2015-2020)
6.3 Japan Fexofenadine Sales Market Share by Type (2015-2020)
6.4 Japan Fexofenadine Sales Market Share by Application (2015-2020)

7 Southeast Asia Fexofenadine Market Facts & Figures
7.2 Southeast Asia Fexofenadine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Fexofenadine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Fexofenadine Sales Market Share by Application (2015-2020)

8 India Fexofenadine Market Facts & Figures
8.2 India Fexofenadine Sales Market Share by Company (2015-2020)
8.3 India Fexofenadine Sales Market Share by Type (2015-2020)
8.4 India Fexofenadine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Fexofenadine Business
12.1 Viruj Pharma
12.1.1 Viruj Pharma Fexofenadine Corporation Information
12.1.2 Viruj Pharma Fexofenadine Business Overview and Total Revenue
12.1.3 Viruj Pharma Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Viruj Pharma Fexofenadine Products Offered
12.1.5 Viruj Pharma Recent Development
12.2 Cemex Pharma
12.2.1 Cemex Pharma Fexofenadine Corporation Information
12.2.2 Cemex Pharma Fexofenadine Business Overview and Total Revenue
12.2.3 Cemex Pharma Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cemex Pharma Fexofenadine Products Offered
12.2.5 Cemex Pharma Recent Development
12.3 Smaart Pharmaceutticals
12.3.1 Smaart Pharmaceutticals Fexofenadine Corporation Information
12.3.2 Smaart Pharmaceutticals Fexofenadine Business Overview and Total Revenue
12.3.3 Smaart Pharmaceutticals Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Smaart Pharmaceutticals Fexofenadine Products Offered
12.3.5 Smaart Pharmaceutticals Recent Development
12.4 Titan Pharma
12.4.1 Titan Pharma Fexofenadine Corporation Information
12.4.2 Titan Pharma Fexofenadine Business Overview and Total Revenue
12.4.3 Titan Pharma Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Titan Pharma Fexofenadine Products Offered
12.4.5 Titan Pharma Recent Development
12.5 AFCL
12.5.1 AFCL Fexofenadine Corporation Information
12.5.2 AFCL Fexofenadine Business Overview and Total Revenue
12.5.3 AFCL Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 AFCL Fexofenadine Products Offered
12.5.5 AFCL Recent Development
12.6 Synkromax
12.6.1 Synkromax Fexofenadine Corporation Information
12.6.2 Synkromax Fexofenadine Business Overview and Total Revenue
12.6.3 Synkromax Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Synkromax Fexofenadine Products Offered
12.6.5 Synkromax Recent Development
12.7 Farmhispania
12.7.1 Farmhispania Fexofenadine Corporation Information
12.7.2 Farmhispania Fexofenadine Business Overview and Total Revenue
12.7.3 Farmhispania Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Farmhispania Fexofenadine Products Offered
12.7.5 Farmhispania Recent Development
12.8 Gen Pharma
12.8.1 Gen Pharma Fexofenadine Corporation Information
12.8.2 Gen Pharma Fexofenadine Business Overview and Total Revenue
12.8.3 Gen Pharma Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Gen Pharma Fexofenadine Products Offered
12.8.5 Gen Pharma Recent Development
12.9 Admiron Life Sciences Private Limited
12.9.1 Admiron Life Sciences Private Limited Fexofenadine Corporation Information
12.9.2 Admiron Life Sciences Private Limited Fexofenadine Business Overview and Total Revenue
12.9.3 Admiron Life Sciences Private Limited Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Admiron Life Sciences Private Limited Fexofenadine Products Offered
12.9.5 Admiron Life Sciences Private Limited Recent Development
12.10 JRC
12.10.1 JRC Fexofenadine Corporation Information
12.10.2 JRC Fexofenadine Business Overview and Total Revenue
12.10.3 JRC Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 JRC Fexofenadine Products Offered
12.10.5 JRC Recent Development
12.11 Archerchem
12.11.1 Archerchem Fexofenadine Corporation Information
12.11.2 Archerchem Fexofenadine Business Overview and Total Revenue
12.11.3 Archerchem Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Archerchem Fexofenadine Products Offered
12.11.5 Archerchem Recent Development
12.12 Sibram
12.12.1 Sibram Fexofenadine Corporation Information
12.12.2 Sibram Fexofenadine Business Overview and Total Revenue
12.12.3 Sibram Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sibram Fexofenadine Products Offered
12.12.5 Sibram Recent Development
12.13 Sumitomo Chemical
12.13.1 Sumitomo Chemical Fexofenadine Corporation Information
12.13.2 Sumitomo Chemical Fexofenadine Business Overview and Total Revenue
12.13.3 Sumitomo Chemical Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Sumitomo Chemical Fexofenadine Products Offered
12.13.5 Sumitomo Chemical Recent Development
12.14 Panchsheel
12.14.1 Panchsheel Fexofenadine Corporation Information
12.14.2 Panchsheel Fexofenadine Business Overview and Total Revenue
12.14.3 Panchsheel Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Panchsheel Fexofenadine Products Offered
12.14.5 Panchsheel Recent Development
12.15 CAMEO HEALTH CARE
12.15.1 CAMEO HEALTH CARE Fexofenadine Corporation Information
12.15.2 CAMEO HEALTH CARE Fexofenadine Business Overview and Total Revenue
12.15.3 CAMEO HEALTH CARE Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 CAMEO HEALTH CARE Fexofenadine Products Offered
12.15.5 CAMEO HEALTH CARE Recent Development
12.16 CEPiA-Sanofi
12.16.1 CEPiA-Sanofi Fexofenadine Corporation Information
12.16.2 CEPiA-Sanofi Fexofenadine Business Overview and Total Revenue
12.16.3 CEPiA-Sanofi Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.16.4 CEPiA-Sanofi Fexofenadine Products Offered
12.16.5 CEPiA-Sanofi Recent Development
12.17 Va Sudha Pharma Chem Limited
12.17.1 Va Sudha Pharma Chem Limited Fexofenadine Corporation Information
12.17.2 Va Sudha Pharma Chem Limited Fexofenadine Business Overview and Total Revenue
12.17.3 Va Sudha Pharma Chem Limited Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Va Sudha Pharma Chem Limited Fexofenadine Products Offered
12.17.5 Va Sudha Pharma Chem Limited Recent Development
12.18 VPL Chemicals
12.18.1 VPL Chemicals Fexofenadine Corporation Information
12.18.2 VPL Chemicals Fexofenadine Business Overview and Total Revenue
12.18.3 VPL Chemicals Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.18.4 VPL Chemicals Fexofenadine Products Offered
12.18.5 VPL Chemicals Recent Development
12.19 Zhejiang Excel Pharmaceutical
12.19.1 Zhejiang Excel Pharmaceutical Fexofenadine Corporation Information
12.19.2 Zhejiang Excel Pharmaceutical Fexofenadine Business Overview and Total Revenue
12.19.3 Zhejiang Excel Pharmaceutical Fexofenadine Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Zhejiang Excel Pharmaceutical Fexofenadine Products Offered
12.19.5 Zhejiang Excel Pharmaceutical Recent Development

13 Fexofenadine Manufacturing Cost Analysis
13.1 Fexofenadine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Fexofenadine
13.4 Fexofenadine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Fexofenadine Distributors List
14.3 Fexofenadine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Fexofenadine Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Fexofenadine Sales (MT) Comparison by Application (2020-2026)
Table 3. Global Market Fexofenadine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Fexofenadine Sales (MT) by Region (2015-2020)
Table 5. Global Fexofenadine Sales Market Share by Region (2015-2020)
Table 6. Global Fexofenadine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Fexofenadine Revenue Share by Region (2015-2020)
Table 8. Global Fexofenadine Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Fexofenadine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Fexofenadine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Fexofenadine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Fexofenadine (MT) of Key Companies (2015-2020)
Table 13. Global Fexofenadine Sales Share by Company (2015-2020)
Table 14. Global Fexofenadine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Fexofenadine Revenue Share by Company (2015-2020)
Table 16. Global Fexofenadine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fexofenadine as of 2019)
Table 17. Global Fexofenadine Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Fexofenadine Manufacturing Sites and Area Served
Table 19. Manufacturers Fexofenadine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Fexofenadine Players
Table 22. Global Fexofenadine Sales (MT) by Type (2015-2020)
Table 23. Global Fexofenadine Sales Share by Type (2015-2020)
Table 24. Global Fexofenadine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Fexofenadine Price (MT) by Type (2015-2020)
Table 26. Global Fexofenadine Sales Share by Type (2021-2026)
Table 27. Global Fexofenadine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Fexofenadine Revenue Share by Type (2021-2026)
Table 29. Global Fexofenadine Price (MT) by Type (2021-2026)
Table 30. Global Fexofenadine Sales (MT) by Application (2015-2020)
Table 31. Global Fexofenadine Sales Share by Application (2015-2020)
Table 32. Global Fexofenadine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Fexofenadine Price (MT) by Application (2015-2020)
Table 34. Global Fexofenadine Sales (MT) by Application (2021-2026)
Table 35. Global Fexofenadine Sales Share by Application (2021-2026)
Table 36. Global Fexofenadine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Fexofenadine Revenue Share by Application (2021-2026)
Table 38. Global Fexofenadine Price (MT) by Application (2021-2026)
Table 39. United States Fexofenadine Sales (MT) by Company (2015-2020)
Table 40. United States Fexofenadine Sales Market Share by Company (2015-2020)
Table 41. United States Fexofenadine Sales (MT) by Type (2015-2020)
Table 42. United States Fexofenadine Sales Market Share by Type (2015-2020)
Table 43. United States Fexofenadine Sales (MT) by Application (2015-2020)
Table 44. United States Fexofenadine Sales Market Share by Application (2015-2020)
Table 45. Europe Fexofenadine Sales (MT) by Company (2015-2020)
Table 46. Europe Fexofenadine Sales Market Share by Company (2015-2020)
Table 47. Europe Fexofenadine Sales (MT) by Type (2015-2020)
Table 48. Europe Fexofenadine Sales Market Share by Type (2015-2020)
Table 49. Europe Fexofenadine Sales (MT) by Application (2015-2020)
Table 50. Europe Fexofenadine Sales Market Share by Type (2015-2020)
Table 51. China Fexofenadine Sales (MT) by Company (2015-2020)
Table 52. China Fexofenadine Sales Market Share by Company (2015-2020)
Table 53. China Fexofenadine Sales (MT) by Type (2015-2020)
Table 54. China Fexofenadine Sales Market Share by Type (2015-2020)
Table 55. China Fexofenadine Sales (MT) by Application (2015-2020)
Table 56. China Fexofenadine Sales Market Share by Application (2015-2020)
Table 57. Japan Fexofenadine Sales (MT) by Company (2015-2020)
Table 58. Japan Fexofenadine Sales Market Share by Company (2015-2020)
Table 59. Japan Fexofenadine Sales (MT) by Type (2015-2020)
Table 60. Japan Fexofenadine Sales Market Share by Type (2015-2020)
Table 61. Japan Fexofenadine Sales (MT) by Application (2015-2020)
Table 62. Japan Fexofenadine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Fexofenadine Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Fexofenadine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Fexofenadine Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Fexofenadine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Fexofenadine Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Fexofenadine Sales Market Share by Application (2015-2020)
Table 69. India Fexofenadine Sales (MT) by Company (2015-2020)
Table 70. India Fexofenadine Sales Market Share by Company (2015-2020)
Table 71. India Fexofenadine Sales (MT) by Type (2015-2020)
Table 72. India Fexofenadine Sales Market Share by Type (2015-2020)
Table 73. India Fexofenadine Sales (MT) by Application (2015-2020)
Table 74. India Fexofenadine Sales Market Share by Application (2015-2020)
Table 75. Viruj Pharma Corporation Information
Table 76. Viruj Pharma Description and Business Overview
Table 77. Viruj Pharma Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Viruj Pharma Fexofenadine Product
Table 79. Viruj Pharma Recent Development
Table 80. Cemex Pharma Corporation Information
Table 81. Cemex Pharma Description and Business Overview
Table 82. Cemex Pharma Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Cemex Pharma Fexofenadine Product
Table 84. Cemex Pharma Recent Development
Table 85. Smaart Pharmaceutticals Corporation Information
Table 86. Smaart Pharmaceutticals Description and Business Overview
Table 87. Smaart Pharmaceutticals Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Smaart Pharmaceutticals Fexofenadine Product
Table 89. Smaart Pharmaceutticals Recent Development
Table 90. Titan Pharma Corporation Information
Table 91. Titan Pharma Description and Business Overview
Table 92. Titan Pharma Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Titan Pharma Fexofenadine Product
Table 94. Titan Pharma Recent Development
Table 95. AFCL Corporation Information
Table 96. AFCL Description and Business Overview
Table 97. AFCL Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. AFCL Fexofenadine Product
Table 99. AFCL Recent Development
Table 100. Synkromax Corporation Information
Table 101. Synkromax Description and Business Overview
Table 102. Synkromax Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Synkromax Fexofenadine Product
Table 104. Synkromax Recent Development
Table 105. Farmhispania Corporation Information
Table 106. Farmhispania Description and Business Overview
Table 107. Farmhispania Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Farmhispania Fexofenadine Product
Table 109. Farmhispania Recent Development
Table 110. Gen Pharma Corporation Information
Table 111. Gen Pharma Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Gen Pharma Description and Business Overview
Table 113. Gen Pharma Fexofenadine Product
Table 114. Gen Pharma Recent Development
Table 115. Admiron Life Sciences Private Limited Corporation Information
Table 116. Admiron Life Sciences Private Limited Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Admiron Life Sciences Private Limited Description and Business Overview
Table 118. Admiron Life Sciences Private Limited Fexofenadine Product
Table 119. Admiron Life Sciences Private Limited Recent Development
Table 120. JRC Corporation Information
Table 121. JRC Description and Business Overview
Table 122. JRC Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. JRC Fexofenadine Product
Table 124. JRC Recent Development
Table 125. Archerchem Corporation Information
Table 126. Archerchem Description and Business Overview
Table 127. Archerchem Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Archerchem Fexofenadine Product
Table 129. Archerchem Recent Development
Table 130. Sibram Corporation Information
Table 131. Sibram Description and Business Overview
Table 132. Sibram Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Sibram Fexofenadine Product
Table 134. Sibram Recent Development
Table 135. Sumitomo Chemical Corporation Information
Table 136. Sumitomo Chemical Description and Business Overview
Table 137. Sumitomo Chemical Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Sumitomo Chemical Fexofenadine Product
Table 139. Sumitomo Chemical Recent Development
Table 140. Panchsheel Corporation Information
Table 141. Panchsheel Description and Business Overview
Table 142. Panchsheel Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Panchsheel Fexofenadine Product
Table 144. Panchsheel Recent Development
Table 145. CAMEO HEALTH CARE Corporation Information
Table 146. CAMEO HEALTH CARE Description and Business Overview
Table 147. CAMEO HEALTH CARE Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. CAMEO HEALTH CARE Fexofenadine Product
Table 149. CAMEO HEALTH CARE Recent Development
Table 150. CEPiA-Sanofi Corporation Information
Table 151. CEPiA-Sanofi Description and Business Overview
Table 152. CEPiA-Sanofi Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. CEPiA-Sanofi Fexofenadine Product
Table 154. CEPiA-Sanofi Recent Development
Table 155. Va Sudha Pharma Chem Limited Corporation Information
Table 156. Va Sudha Pharma Chem Limited Description and Business Overview
Table 157. Va Sudha Pharma Chem Limited Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Va Sudha Pharma Chem Limited Fexofenadine Product
Table 159. Va Sudha Pharma Chem Limited Recent Development
Table 160. VPL Chemicals Corporation Information
Table 161. VPL Chemicals Description and Business Overview
Table 162. VPL Chemicals Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. VPL Chemicals Fexofenadine Product
Table 164. VPL Chemicals Recent Development
Table 165. Zhejiang Excel Pharmaceutical Corporation Information
Table 166. Zhejiang Excel Pharmaceutical Description and Business Overview
Table 167. Zhejiang Excel Pharmaceutical Fexofenadine Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Zhejiang Excel Pharmaceutical Fexofenadine Product
Table 169. Zhejiang Excel Pharmaceutical Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Fexofenadine Distributors List
Table 173. Fexofenadine Customers List
Table 174. Market Key Trends
Table 175. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 176. Key Challenges
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Fexofenadine Product Picture
Figure 2. Global Fexofenadine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Fexofenadine Market Share by Application in 2020 & 2026
Figure 6. Hay Fever Treatment Examples
Figure 7. Urticaria Treatment Examples
Figure 8. Global Fexofenadine Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Fexofenadine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Fexofenadine Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Fexofenadine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Fexofenadine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Fexofenadine Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Fexofenadine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Fexofenadine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Fexofenadine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Fexofenadine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Fexofenadine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Fexofenadine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Fexofenadine Players Market Share by Revenue in Fexofenadine 2015 & 2019
Figure 26. Fexofenadine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Fexofenadine Revenue Share by Type (2015-2020)
Figure 28. Global Fexofenadine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Fexofenadine Revenue Share by Application (2015-2020)
Figure 30. Global Fexofenadine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Fexofenadine Sales Market Share by Type in 2019
Figure 32. United States Fexofenadine Sales Market Share by Type in 2019
Figure 33. Europe Fexofenadine Sales Market Share by Company in 2019
Figure 34. Europe Fexofenadine Sales Market Share by Type in 2019
Figure 35. Europe Fexofenadine Sales Market Share by Application in 2019
Figure 36. China Fexofenadine Sales Market Share by Company in 2019
Figure 37. China Fexofenadine Sales Market Share by Type in 2019
Figure 38. China Fexofenadine Sales Market Share by Application in 2019
Figure 39. Japan Fexofenadine Sales Market Share by Company in 2019
Figure 40. Japan Fexofenadine Sales Market Share by Type in 2019
Figure 41. Japan Fexofenadine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Fexofenadine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Fexofenadine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Fexofenadine Sales Market Share by Application in 2019
Figure 45. India Fexofenadine Sales Market Share by Company in 2019
Figure 46. India Fexofenadine Sales Market Share by Type in 2019
Figure 47. India Fexofenadine Sales Market Share by Application in 2019
Figure 48. Viruj Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cemex Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Smaart Pharmaceutticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Titan Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. AFCL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Synkromax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Farmhispania Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Gen Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Admiron Life Sciences Private Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. JRC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Archerchem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Sibram Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Sumitomo Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Panchsheel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. CAMEO HEALTH CARE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. CEPiA-Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Va Sudha Pharma Chem Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. VPL Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Zhejiang Excel Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Key Raw Materials Price Trend
Figure 68. Manufacturing Cost Structure of Fexofenadine
Figure 69. Manufacturing Process Analysis of Fexofenadine
Figure 70. Fexofenadine Industrial Chain Analysis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. Porter's Five Forces Analysis
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed